Image-guided Therapy Systems Market Worth $4.95 Billion by 2025: Grand View Research, Inc.

Thursday, October 4, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, October 4, 2018 /PRNewswire/ --

The global image-guided therapy systems market size is

expected to reach USD 4.95 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to exhibit a healthy CAGR of 6.3% during the forecast period. Growing geriatric population base and
cases of chronic diseases are expected to boost the market demand. Other factors propelling the market growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy is also one of the important factors driving the market.

     (Logo: )

New product launches by major companies is also having a positive impact on the market development. For instance, in February 2017, Philips launched a next-generation image guided therapy platform called Azurion for advancing patient care. Growing adoption of such advanced systems is expected to drive the market. Development of this system was aimed at optimizing interventional lab performance, thereby ensuring superior care delivery. Increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on the market growth.

In addition, many academic institutions are also investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute toward market expansion. The development of Image-guided Therapy Program by the Brigham and Women's Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.

Browse full research report with TOC on "Image-guided Therapy Systems Market Size, Share & Trends Analysis Report By End Use (ASCs, Clinics, Hospitals), By Product (MRI, PET), By Application (Neurosurgery, Urology), And Segment Forecasts, 2018 - 2025" at:

Further Key Findings From the Report Suggest: 

  • Endoscopes segment accounted for the largest revenue share in 2017 owing to technological advancements, high volume of endoscope-guided surgeries, and rising preference for minimally invasive surgeries
  • Cardiac surgery emerged as the largest application segment in 2017. This growth is attributed to rising prevalence of target diseases, preference for minimally invasive cardiac surgeries, and R&D initiatives aimed at developing real-time cardiac interventions systems
  • Hospitals emerged as the largest end-use segment in 2017. However, Ambulatory Surgery Centers (ASCs) segment is projected to expand at the fastest CAGR of 7.3% over the forecast period
  • North America emerged as the largest regional market. Asia Pacific is anticipated to exhibit the fastest growth rate of 7.6% during the forecast period
  • The market is consolidated with the presence of Koninklijke Philips N.V., Siemens Healthineers, GE Healthcare, and Fujifilm Holdings Corporation accounting for the majority market share. Analogic Corporation; Varian Medical Systems, Inc.; Brainlab AG; Medtronic PLC; and Stryker Corp. are several other prominent companies in the market.

Browse related reports by Grand View Research: 

  • Platelet Rich Plasma (PRP) Market - The global platelet rich plasma (PRP) market size was valued at USD 214.3 million in 2016 and is expected to grow at a CAGR of 13.3% over the forecast period.
  • Body Fat Measurement Market - The global body fat measurement market size was valued at USD 475.86 million in 2016. It is expected to expand at a CAGR of 8.4% during the forecast horizon.
  • Facial Injectables Market - The global facial injectables market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of 11.5% during the forecast period.
  • Burn Care Market - The global burn care market size was estimated at USD 1.66 billion in 2016. 

Grand View Research has segmented the global image-guided therapy systems market on the basis of product, application, end use, and region: 

  • Image-guided Therapy Systems Product Outlook (Revenue, USD Million, 2014 - 2025) 
    • Computed Tomography (CT) Scanners
    • Ultrasound Systems
    • Magnetic Resonance Imaging (MRI)
    • Endoscope
    • X-ray Fluoroscopy
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
  • Image-guided Therapy Systems Application Outlook (Revenue, USD Million, 2014 - 2025) 
    • Cardiac Surgery
    • Neurosurgery
    • Orthopedic Surgery
    • Urology
    • Gastroenterology
    • Oncology Surgery
    • Others
  • Image-guided Therapy Systems End-use Outlook (Revenue, USD Million, 2014 - 2025) 
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Clinics
    • Research & Academic Institutes
  • Image-guided Therapy Systems Regional Outlook (Revenue, USD Million, 2014 - 2025) 
    • North America
      • U.S.
    • Europe
      • Germany
      • U.K.
      • France
      • Russia
      • Italy
      • Spain
      • Netherlands
      • Sweden
    • Asia Pacific
      • China
      • India
      • Australia
      • Singapore
    • Latin America
      • Brazil
    • Middle East & Africa
      • South Africa
      • Saudi Arabia

Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email:


SOURCE Grand View Research, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store